BofA raised the firm’s price target on McKesson to $670 from $590 and keeps a Buy rating on the shares after Independent Pharmacy Cooperative, which the firm identifies as one of the largest group purchasing organizations to community pharmacies, signed a new supply agreement with the company. The firm had previously thought that it would be more difficult to award McKesson a higher multiple, but the IPC news points to more industry stability, which provides it with greater confidence in McKesson’s intermediate term growth algorithm, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson participates in a conference call with JPMorgan
- McKesson CEO sells $2.16M in common stock
- McKesson Announces Board Changes, Welcomes Dr. Dunsire
- Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 05/17/2024
- Third Point takes new position in Alphabet, exits U.S. Steel
Questions or Comments about the article? Write to editor@tipranks.com